Description
Added on the 01/02/2021 10:03:18 - Copyright : Euronews EN
Berlin (Germany), Feb 1 (EFE / EPA), (ARCHIVE).- The German company BioNTech announced Monday that it will supply the EU with 75 million doses of its Covid-19 vaccine in the second quarter of the year after optimizing its production process. ARCHIVE FOOTAGE OF BIONTECH HEADQUARTERS IN MAINZ AND VACCINATION CAMPAIGN IN STUTTGART, GERMANY.
On Wednesday, Pfizer and BioNTech announced having reached a deal with the U.S. government with an additional 100 million doses by July 31. That's up from the initial 100 million doses ordered already. The deal follows a similar extension of doses reached by the U.S. with Moderna for their vaccine. Both vaccines require two doses to be administered. The $2 billion deal calls for at least an additional 70 million doses to be provided to the U.S. by June 30. The remaining 30 million doses needing to be delivered by July 31. It also allows for the U.S. to obtain up to an additional 400 million doses in the future.
The US government has ordered another 100 million doses of Moderna's coronavirus vaccine. This brings the total number of vaccines ordered to 200 million, says Business Insider. If the vaccine receives emergency-use authorization from the FDA, Moderna plans to deliver. The delivery will be for 20 million doses by the end of December with the rest over the start of 2021. The US still has the option to purchase another 300 million doses from Moderna. Everyone who wants the vaccine should be able to get one, timing is the main concern.
The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its Covid-19 vaccine, European Commission chief Ursula von der Leyen says at a media conference in Porto, Portugal. SOUNDBITE
|
Support : Technical 
- Content 
- Editors 
